MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6 | -82.9% | 40,873 | -74.9% | 0.00% | -100.0% |
| Q4 2023 | $35 | +6.1% | 162,885 | +80.4% | 0.00% | 0.0% |
| Q2 2023 | $33 | -54.2% | 90,298 | -37.3% | 0.00% | -70.0% |
| Q4 2022 | $72 | -99.6% | 144,095 | +448.6% | 0.01% | +400.0% |
| Q3 2022 | $17,000 | -76.7% | 26,265 | -71.4% | 0.00% | -66.7% |
| Q2 2022 | $73,000 | -15.1% | 91,951 | +8.5% | 0.01% | -33.3% |
| Q4 2021 | $86,000 | -71.3% | 84,712 | -63.3% | 0.01% | -65.4% |
| Q3 2021 | $300,000 | +368.8% | 230,865 | +390.4% | 0.03% | +271.4% |
| Q4 2020 | $64,000 | -80.8% | 47,073 | -67.9% | 0.01% | -78.1% |
| Q4 2019 | $333,000 | +1232.0% | 146,772 | +393.9% | 0.03% | +3100.0% |
| Q2 2019 | $25,000 | -80.3% | 29,716 | -74.5% | 0.00% | -85.7% |
| Q1 2019 | $127,000 | +225.6% | 116,636 | +80.0% | 0.01% | +250.0% |
| Q4 2018 | $39,000 | -68.3% | 64,783 | -39.0% | 0.00% | -71.4% |
| Q4 2017 | $123,000 | +98.4% | 106,146 | +126.0% | 0.01% | +133.3% |
| Q3 2017 | $62,000 | – | 46,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,492,000 | $552,784 | 0.11% |
| Alliance Wealth Management Group | 1,886,715 | $298,667 | 0.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,644,331 | $1,684,998 | 0.05% |
| Towercrest Capital Management | 1,886,715 | $298,667 | 0.05% |
| NEVILLE RODIE & SHAW INC | 1,157,332 | $183 | 0.01% |
| Platform Technology Partners | 156,250 | $24,734 | 0.01% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $123 | 0.01% |
| Main Street Financial Solutions, LLC | 400,826 | $63,451 | 0.01% |
| National Wealth Management Group, LLC | 38,250 | $6,055 | 0.01% |
| STALEY CAPITAL ADVISERS INC | 400,000 | $63,320 | 0.00% |